Seven in 19 relatives of patients who had BRCA1/2 gene mutations received genetic counseling for the risk of ovarian and breast cancer, in addition to screening methods and prophylactic measures according to the recommendation of the National Comprehensive Cancer Network (NCCN) [29]. This evidence concerns the gene BRCA1 and breast carcinoma.